HomeComparePCRFF vs PFE

PCRFF vs PFE: Dividend Comparison 2026

PCRFF yields 2.10% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $16.3K in total portfolio value· pulled ahead in Year 10
10 years
PCRFF
PCRFF
● Live price
2.10%
Share price
$15.25
Annual div
$0.32
5Y div CAGR
25%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33.3K
Annual income
$3,006.24
Full PCRFF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — PCRFF vs PFE

📍 PFE pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPCRFFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PCRFF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PCRFF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCRFF
Annual income on $10K today (after 15% tax)
$178.12/yr
After 10yr DRIP, annual income (after tax)
$2,555.30/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $19,764.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCRFF + PFE for your $10,000?

PCRFF: 50%PFE: 50%
100% PFE50/50100% PCRFF
Portfolio after 10yr
$41.4K
Annual income
$14,632.48/yr
Blended yield
35.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

PCRFF
No analyst data
Altman Z
2.1
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCRFF buys
0
PFE buys
0
No recent congressional trades found for PCRFF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPCRFFPFE
Forward yield2.10%6.13%
Annual dividend / share$0.32$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR25%13.2%
Portfolio after 10y$33.3K$49.6K
Annual income after 10y$3,006.24$26,258.71
Total dividends collected$11.4K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PCRFF vs PFE ($10,000, DRIP)

YearPCRFF PortfolioPCRFF Income/yrPFE PortfolioPFE Income/yrGap
1$10,962$261.93$9,153$693.39+$1.8KPCRFF
2$12,065$335.43$8,593$849.25+$3.5KPCRFF
3$13,341$431.28$8,336$1,066.78+$5.0KPCRFF
4$14,831$557.11$8,437$1,384.80+$6.4KPCRFF
5$16,593$723.57$9,013$1,875.40+$7.6KPCRFF
6$18,700$945.70$10,306$2,680.72+$8.4KPCRFF
7$21,255$1,245.09$12,820$4,101.38+$8.4KPCRFF
8$24,396$1,653.21$17,673$6,826.70+$6.7KPCRFF
9$28,320$2,216.74$27,543$12,591.86+$777.00PCRFF
10← crossover$33,309$3,006.24$49,560$26,258.71$16.3KPFE

PCRFF vs PFE: Complete Analysis 2026

PCRFFStock

Panasonic Holdings Corporation, together with its subsidiaries, develops, manufactures, sells, and services various electrical and electronic products worldwide. It operates through Appliances, Life Solutions, Connected Solutions, Automotive, and Industrial Solutions segments. The Appliances segment offers air conditioners, refrigerators, washing machines, vacuum cleaners, microwave ovens, rice cookers, personal care products, TVs, digital cameras, video equipment, home audio equipment, fixed-phones, show cases, compressors, and fuel cells. The Life Solutions segment provides lighting fixtures, lamps, wiring devices, solar photovoltaic systems, spatial sterilizing/deodorizing equipment, interior and exterior furnishing materials, ventilation and air conditioning equipment, air purifiers, bicycles, and nursing care related products, as well as kitchen and bath products. The Connected Solutions segment offers aircraft in-flight entertainment systems and communications services, electronic component mounting machines, welding equipment, PCs and tablets, projectors, and professional AV systems, as well as solutions for various industries. The Automotive segment provides automotive-use infotainment systems, head-up displays, automotive audio systems, automotive switches, vehicle camera modules, advanced driver assistance systems, automotive mirrors, and cylindrical and prismatic lithium-ion batteries, as well as devices and systems for electric automobiles. The Industrial Solutions segment offers relays, switches, power supply products, industrial motors and sensors, capacitors, coils, resistors, electronic circuit board materials, semiconductors, and LCD panels, as well as small lithium–ion, dry, and micro batteries. The company was formerly known as Panasonic Corporation. Panasonic Holdings Corporation was founded in 1918 and is headquartered in Kadoma, Japan.

Full PCRFF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this PCRFF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCRFF vs SCHDPCRFF vs JEPIPCRFF vs OPCRFF vs KOPCRFF vs MAINPCRFF vs JNJPCRFF vs MRKPCRFF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.